September 30, 2021

The SatioPatch™ Platform provides consumer-based diagnosis and eliminates the need for needles administered by a medical professional.

Technology that allows real-time, accurate detection of a wide range of specific targets, and delivers results within minutes.


Sapphiros has today completed the acquisition of Flexotronix Limited.
Satio and INTACT Solutions have entered into an agreement to establish a collaborative framework in order to partner on research, development, manufacture, and deployment of next generation health technologies with the goal of offering alternative solutions to traditional needles with SatioRx™ intradermal patches for the Member States of the African Union and beyond.